共 50 条
- [7] RETRACTION: Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation (Retraction of Vol 12, Pg 1, 2018) DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 4019 - 4019
- [9] RETRACTION: Overexpression of Chloride Channel-3 Predicts Unfavorable Prognosis and Promotes Cellular Invasion in Gastric Cancer (Retraction of Vol 10, Pg 1163, 2018) CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 465 - 465